Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Immunoblastic × Alemtuzumab × 1 year × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Transplantation 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Adenocarcinoma, Clear Cell 1

Interventions

Cyclophosphamide 4 Etoposide 3 Vincristine 2 Rituximab 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Doxorubicin 2 fludarabine phosphate 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Lenalidomide 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Filgrastim 1 Cyclosporine 1 Carmustine 1 Busulfan 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡